Ocular Therapeutix (OCUL) Stock Chart & Stock Price History → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free OCUL Stock Alerts $5.22 -0.64 (-10.92%) (As of 04/19/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Ocular Therapeutix Stock Price Performance5 Day Performance-34.67%1 Month Performance-46.19%3 Month Performance+35.58%6 Month Performance+125.49%Year-To-Date Performance+17.04%1 Year Performance-10.31% Receive OCUL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ocular Therapeutix and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! OCUL Stock Chart for Friday, April, 19, 2024 OCUL Chart by TradingView Ocular Therapeutix Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024$7.58$5.86-22.69%$7.61$5.866.07 million shs$870.97 million04/17/2024$7.79$7.58-2.70%$8.15$7.58982,740 shs$1.13 billion04/16/2024$7.80$7.79-0.13%$7.94$7.531.34 million shs$1.16 billion04/15/2024$7.99$7.80-2.38%$7.96$7.581.49 million shs$1.16 billion04/12/2024$8.28$7.99-3.50%$8.35$7.881.04 million shs$1.19 billion04/11/2024$7.91$8.28+4.68%$8.29$7.831.21 million shs$1.23 billion Get the Latest News and Ratings for OCUL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocular Therapeutix and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024$8.17$7.91-3.18%$8.01$7.582.21 million shs$1.18 billion04/09/2024$7.99$8.17+2.25%$8.19$7.951.32 million shs$1.21 billion04/08/2024$8.44$7.99-5.33%$8.86$7.932.13 million shs$1.19 billion04/05/2024$8.47$8.44-0.35%$8.74$8.311.44 million shs$1.25 billion04/04/2024$8.45$8.47+0.24%$8.94$8.391.07 million shs$1.26 billion04/03/2024$8.48$8.45-0.35%$8.55$8.31814,711 shs$1.26 billion04/02/2024$8.69$8.48-2.42%$8.68$8.331.07 million shs$1.26 billion04/01/2024$9.10$8.69-4.51%$9.10$8.561.72 million shs$1.29 billion03/29/2024$9.10$9.10$9.50$9.062.20 million shs$1.35 billion03/28/2024$9.31$9.10-2.26%$9.50$9.062.20 million shs$1.35 billion03/27/2024$9.20$9.31+1.20%$9.54$9.131.07 million shs$1.38 billion03/26/2024$9.41$9.20-2.23%$9.59$8.971.39 million shs$1.37 billion03/25/2024$9.49$9.41-0.84%$9.79$9.27926,955 shs$1.40 billion03/22/2024$10.15$9.49-6.50%$10.25$9.481.42 million shs$1.41 billion03/21/2024$9.90$10.15+2.53%$10.28$9.591.68 million shs$1.51 billion03/20/2024$9.70$9.90+2.06%$9.97$9.481.33 million shs$1.47 billion03/19/2024$9.44$9.70+2.75%$9.72$9.251.52 million shs$1.44 billion03/18/2024$9.46$9.44-0.21%$9.63$8.961.76 million shs$1.40 billion03/15/2024$9.26$9.46+2.16%$9.86$9.249.66 million shs$751.31 million03/14/2024$9.59$9.26-3.44%$9.67$9.022.18 million shs$735.43 million03/13/2024$9.29$9.59+3.23%$10.05$9.433.14 million shs$761.64 million03/12/2024$9.73$9.29-4.52%$10.34$8.833.32 million shs$737.81 million03/11/2024$9.98$9.73-2.51%$10.02$9.662.12 million shs$772.75 million03/08/2024$10.37$9.98-3.76%$10.65$9.882.04 million shs$792.61 million03/07/2024$10.83$10.37-4.25%$10.96$10.271.94 million shs$823.59 million03/06/2024$10.93$10.83-0.91%$11.31$10.623.00 million shs$860.12 million03/05/2024$10.88$10.93+0.46%$11.02$10.551.91 million shs$868.06 million03/04/2024$10.75$10.88+1.21%$11.29$10.302.37 million shs$864.09 million03/01/2024$10.06$10.75+6.86%$10.91$10.032.61 million shs$853.77 million02/29/2024$9.95$10.06+1.11%$10.36$9.723.22 million shs$798.97 million02/28/2024$9.90$9.95+0.51%$10.48$9.762.83 million shs$790.23 million02/27/2024$9.90$9.90$10.29$9.732.74 million shs$786.26 million02/26/2024$9.86$9.90+0.41%$10.54$9.563.15 million shs$786.25 million02/23/2024$9.70$9.86+1.65%$10.00$9.343.96 million shs$783.08 millionTiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>>02/22/2024$7.52$9.70+28.99%$9.91$8.8311.04 million shs$770.37 million02/21/2024$7.52$7.52$7.71$7.301.66 million shs$597.24 million02/20/2024$7.58$7.52-0.79%$7.78$7.172.63 million shs$597.24 million02/19/2024$7.58$7.58$7.72$6.683.19 million shs$602.00 million02/16/2024$6.86$7.58+10.50%$7.71$6.683.19 million shs$602.00 million02/15/2024$6.46$6.86+6.19%$6.91$6.372.47 million shs$544.82 million02/14/2024$5.62$6.46+14.95%$6.52$5.681.89 million shs$513.05 million02/13/2024$5.88$5.62-4.42%$5.78$5.541.33 million shs$446.34 million02/12/2024$5.68$5.88+3.52%$6.07$5.622.38 million shs$466.99 million02/09/2024$5.03$5.68+12.92%$5.85$5.213.69 million shs$451.11 million02/08/2024$5.00$5.03+0.60%$5.27$4.96673,561 shs$399.48 million02/07/2024$5.04$5.00-0.79%$5.08$4.96545,385 shs$397.10 million02/06/2024$4.95$5.04+1.82%$5.11$4.83661,270 shs$400.28 million02/05/2024$5.18$4.95-4.44%$5.10$4.721.35 million shs$393.13 million02/02/2024$5.25$5.18-1.33%$5.32$5.041.02 million shs$411.39 million02/01/2024$4.86$5.25+8.02%$5.40$4.841.43 million shs$416.96 million01/31/2024$4.92$4.86-1.22%$5.07$4.801.17 million shs$385.98 million01/30/2024$5.11$4.92-3.72%$5.11$4.701.39 million shs$390.75 million01/29/2024$4.66$5.11+9.66%$5.14$4.601.73 million shs$405.84 million01/26/2024$4.29$4.66+8.62%$4.68$4.301.77 million shs$370.10 million01/25/2024$4.01$4.29+6.98%$4.51$4.111.27 million shs$340.71 million01/24/2024$4.14$4.01-3.14%$4.28$4.01451,871 shs$318.47 million01/23/2024$4.07$4.14+1.72%$4.20$3.92921,185 shs$328.80 million01/22/2024$3.85$4.07+5.71%$4.12$3.851.41 million shs$323.24 million01/19/2024$3.93$3.85-2.04%$4.00$3.762.20 million shs$305.77 million01/18/2024$4.15$3.93-5.30%$4.16$3.89995,709 shs$312.12 million Related Companies: COLL Stock Chart XNCR Stock Chart PRTA Stock Chart ABCL Stock Chart MIRM Stock Chart DCPH Stock Chart CNTA Stock Chart IMNM Stock Chart MNKD Stock Chart KNSA Stock Chart Receive OCUL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ocular Therapeutix and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OCUL) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlace1970’s computer coder issues shocking A.I. warningTradeSmithTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocular Therapeutix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.